Decision Considerations - Aerospace Medical Dispositions
Item 41. G-U System - Neoplastic Disorders

G-U System - Neoplastic Disorders - All Classes

Disease/Condition Evaluation Data Disposition
All G-U Cancers when treatment was completed more than 5 years ago and there is no history of metastatic disease. (If less than 5 years, see below.) Interview airman Currently cancer-free and released from oncology care - Issue and warn for recurrence.

All others - see below
All G-U cancers when treatment was completed less than 5 years ago or for which there is a history of metastatic disease Submit a current status report, all pertinent medical reports to include staging, metastatic work up, and operative report if applicable. Requires FAA Decision
Bladder Submit all pertinent medical records, operative/pathology reports, current oncological status report, including tumor markers, and any other testing deemed necessary report, include duration of symptoms, name and dosage of drugs and side effects Initial Special Issuance - Requires FAA Decision





Followup Special Issuance - See AASI Protocol
Other Neoplastic Disorders Submit a current status report, all pertinent medical reports to include staging, metastatic work up, and operative report if applicable Requires FAA Decision
Prostatic Cancer Review a current status report, all pertinent medical reports to include staging, PSA, metastatic workup, and operative report, if applicable, and treatment For prostate cancer without evidence of extra-capsular disease - Issue and warn for adverse change in disease and extra-capsular spread/metastases.

All others require FAA Decision. Submit all evaluation data.

Initial Special Issuance - Requires FAA Decision

Followup Special Issuances - See AASI Protocol
Renal Carcinoma Review all pertinent medical records, operative/pathology reports, current oncological status report, including tumor markers, and any other testing deemed necessary report, include duration of symptoms, name and dosage of drugs and side effects See CACI Renal Cancer Worksheet. (PDF) If airman meets all certification criteria - Issue.

All others require FAA decision. Submit all evaluation Data.

Initial Special Issuance - Requires FAA Decision

Followup Special
Issuances
- See AASI Protocol
Testicular Cancer
A. Non metastatic and treatment completed more than 5 years ago No recurrence or ongoing treatment: ISSUE
Summarize this history in Block 60.
B. Non metastatic and treatment completed less than 5 years ago See CACI worksheet (PDF) Follow the CACI Testicular Cancer Worksheet (PDF)

Note in Block 60.

C. Metastatic disease
Current OR anytime in the past

Recurrence of disease

Submit the following to the FAA review:

☐ Current status report from oncologist describing treatment plan and prognosis;

☐ List of medications with attention to any chemotherapy agents and dates used;

☐ Treatment records including clinic notes or summary letter describing disease course and initial staging;

☐ Operative notes and discharge summary (if applicable);

☐ Pathology report(s) (if applicable);

☐ MRI/CT or PET scan reports (in some cases, the actual CDs will be required in DICOM format for FAA review); and

☐ Serum tumor markers results (if applicable).

DEFER
Submit the information to the FAA for a possible Special Issuance.

Notes regarding Testicular Cancer: If the airman is currently on radiation or chemotherapy, the treatment course must be completed before medical certification can be considered.

Watchful waiting is allowed. See CACI Testicular Cancer Worksheet (PDF).